Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3674608013 | Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3674609017 | Product containing precisely hydrocortisone (as hydrocortisone sodium succinate) 2.5 milligram/1 each conventional release oromucosal lozenge (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Is a | Hydrocortisone topical preparation | false | Inferred relationship | Some | ||
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Has active ingredient | Adrenal hormone | false | Inferred relationship | Some | ||
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Has active ingredient | Hydrocortisone (substance) | false | Inferred relationship | Some | ||
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Some | ||
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Has manufactured dose form | Oromucosal lozenge | true | Inferred relationship | Some | ||
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Has basis of strength substance (attribute) | Hydrocortisone (substance) | true | Inferred relationship | Some | 1 | |
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Has unit of presentation | Lozenge | true | Inferred relationship | Some | ||
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Has presentation strength numerator value | 2.5 | false | Inferred relationship | Some | 1 | |
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Has presentation strength denominator unit (attribute) | Lozenge | true | Inferred relationship | Some | 1 | |
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Has precise active ingredient | Hydrocortisone sodium succinate | true | Inferred relationship | Some | 1 | |
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Is a | Hydrocortisone-containing product in oromucosal dose form | false | Inferred relationship | Some | ||
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge | Is a | Product containing only hydrocortisone in oromucosal dose form (medicinal product form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR